Depemokimab trials for Pulmonary Disease, Chronic Obstructive

All Depemokimab trials · All Pulmonary Disease, Chronic Obstructive trials

Phase breakdown

Recruiting trials studying Depemokimab for Pulmonary Disease, Chronic Obstructive

• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
  NCT06959095 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 15 locations
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
  NCT06961214 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 159 locations
• eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
  NCT07177339 · Phase: Phase 3 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 121 locations

Common questions

How many trials study Depemokimab for Pulmonary Disease, Chronic Obstructive?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.